Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120,538,577
-
Total 13F shares
-
7,732,309
-
Share change
-
-2,419,998
-
Total reported value
-
$14,008,817
-
Put/Call ratio
-
54%
-
Price per share
-
$1.81
-
Number of holders
-
42
-
Value change
-
-$4,024,379
-
Number of buys
-
23
-
Number of sells
-
17
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) as of Q4 2024
As of 31 Dec 2024 REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) had 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,732,309 shares of stock of the company.
Largest 10 holders included MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, Schonfeld Strategic Advisors LLC, Parkman Healthcare Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TANG CAPITAL MANAGEMENT LLC, Persistent Asset Partners Ltd, and BlackRock, Inc..
This table shows 42 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.